Andhra Cements Limited

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ULTRACEMCO.NS has a market cap of 3.2T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ULTRACEMCO.NS trades at ₹10,423.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ULTRACEMCO.NS's P/E ratio is 41.20. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ULTRACEMCO.NS's ROE of +0.10%. Regarding short-term risk, ACL.BO is more volatile compared to ULTRACEMCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ULTRACEMCO.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ULTRACEMCO.BO has a market cap of 3.2T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ULTRACEMCO.BO trades at ₹10,713.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ULTRACEMCO.BO's P/E ratio is 41.20. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ULTRACEMCO.BO's ROE of +0.10%. Regarding short-term risk, ACL.BO is more volatile compared to ULTRACEMCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ULTRACEMCO.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GRASIM.BO has a market cap of 1.8T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GRASIM.BO trades at ₹2,593.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GRASIM.BO's P/E ratio is 40.70. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GRASIM.BO's ROE of +0.03%. Regarding short-term risk, ACL.BO is less volatile compared to GRASIM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check GRASIM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GRASIM.NS has a market cap of 1.8T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GRASIM.NS trades at ₹2,526.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GRASIM.NS's P/E ratio is 38.84. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GRASIM.NS's ROE of +0.03%. Regarding short-term risk, ACL.BO is more volatile compared to GRASIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check GRASIM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, AMBUJACEM.NS has a market cap of 1T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while AMBUJACEM.NS trades at ₹408.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas AMBUJACEM.NS's P/E ratio is 28.19. In terms of profitability, ACL.BO's ROE is -1.06%, compared to AMBUJACEM.NS's ROE of +0.06%. Regarding short-term risk, ACL.BO is more volatile compared to AMBUJACEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check AMBUJACEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, AMBUJACEM.BO has a market cap of 1T. Regarding current trading prices, ACL.BO is priced at ₹42.63, while AMBUJACEM.BO trades at ₹420.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas AMBUJACEM.BO's P/E ratio is 28.04. In terms of profitability, ACL.BO's ROE is -1.06%, compared to AMBUJACEM.BO's ROE of +0.06%. Regarding short-term risk, ACL.BO is more volatile compared to AMBUJACEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check AMBUJACEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SHREECEM.BO has a market cap of 839.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SHREECEM.BO trades at ₹23,268.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SHREECEM.BO's P/E ratio is 48.87. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SHREECEM.BO's ROE of +0.08%. Regarding short-term risk, ACL.BO is more volatile compared to SHREECEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SHREECEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SHREECEM.NS has a market cap of 839.4B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SHREECEM.NS trades at ₹22,900.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SHREECEM.NS's P/E ratio is 46.79. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SHREECEM.NS's ROE of +0.08%. Regarding short-term risk, ACL.BO is more volatile compared to SHREECEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SHREECEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JKCEMENT.BO has a market cap of 398.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JKCEMENT.BO trades at ₹5,151.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JKCEMENT.BO's P/E ratio is 39.02. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JKCEMENT.BO's ROE of +0.17%. Regarding short-term risk, ACL.BO is more volatile compared to JKCEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check JKCEMENT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JKCEMENT.NS has a market cap of 397.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JKCEMENT.NS trades at ₹5,024.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JKCEMENT.NS's P/E ratio is 38.92. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JKCEMENT.NS's ROE of +0.17%. Regarding short-term risk, ACL.BO is more volatile compared to JKCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check JKCEMENT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, DALBHARAT.NS has a market cap of 338.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while DALBHARAT.NS trades at ₹1,774.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas DALBHARAT.NS's P/E ratio is 28.59. In terms of profitability, ACL.BO's ROE is -1.06%, compared to DALBHARAT.NS's ROE of +0.07%. Regarding short-term risk, ACL.BO is more volatile compared to DALBHARAT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check DALBHARAT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, DALBHARAT.BO has a market cap of 338.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while DALBHARAT.BO trades at ₹1,804.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas DALBHARAT.BO's P/E ratio is 28.55. In terms of profitability, ACL.BO's ROE is -1.06%, compared to DALBHARAT.BO's ROE of +0.07%. Regarding short-term risk, ACL.BO is less volatile compared to DALBHARAT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check DALBHARAT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ACC.NS has a market cap of 249.4B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ACC.NS trades at ₹1,295.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ACC.NS's P/E ratio is 9.43. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ACC.NS's ROE of +0.14%. Regarding short-term risk, ACL.BO is more volatile compared to ACC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ACC.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ACC.BO has a market cap of 249.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ACC.BO trades at ₹1,327.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ACC.BO's P/E ratio is 9.43. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ACC.BO's ROE of +0.14%. Regarding short-term risk, ACL.BO is less volatile compared to ACC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ACC.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, RAMCOCEM.BO has a market cap of 223B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while RAMCOCEM.BO trades at ₹943.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas RAMCOCEM.BO's P/E ratio is 38.78. In terms of profitability, ACL.BO's ROE is -1.06%, compared to RAMCOCEM.BO's ROE of +0.08%. Regarding short-term risk, ACL.BO is more volatile compared to RAMCOCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check RAMCOCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, RAMCOCEM.NS has a market cap of 222.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while RAMCOCEM.NS trades at ₹908.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas RAMCOCEM.NS's P/E ratio is 38.70. In terms of profitability, ACL.BO's ROE is -1.06%, compared to RAMCOCEM.NS's ROE of +0.08%. Regarding short-term risk, ACL.BO is more volatile compared to RAMCOCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check RAMCOCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JSWCEMENT.NS has a market cap of 153.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JSWCEMENT.NS trades at ₹112.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JSWCEMENT.NS's P/E ratio is -14.04. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JSWCEMENT.NS's ROE of -0.26%. Regarding short-term risk, ACL.BO is more volatile compared to JSWCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check JSWCEMENT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JSWCEMENT.BO has a market cap of 153.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JSWCEMENT.BO trades at ₹114.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JSWCEMENT.BO's P/E ratio is -14.04. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JSWCEMENT.BO's ROE of -0.26%. Regarding short-term risk, ACL.BO is more volatile compared to JSWCEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check JSWCEMENT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, INDIACEM.NS has a market cap of 110.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while INDIACEM.NS trades at ₹351.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas INDIACEM.NS's P/E ratio is -101.77. In terms of profitability, ACL.BO's ROE is -1.06%, compared to INDIACEM.NS's ROE of -0.01%. Regarding short-term risk, ACL.BO is more volatile compared to INDIACEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check INDIACEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, INDIACEM.BO has a market cap of 110.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while INDIACEM.BO trades at ₹356.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas INDIACEM.BO's P/E ratio is -101.70. In terms of profitability, ACL.BO's ROE is -1.06%, compared to INDIACEM.BO's ROE of -0.01%. Regarding short-term risk, ACL.BO is more volatile compared to INDIACEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check INDIACEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NUVOCO.NS has a market cap of 103.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NUVOCO.NS trades at ₹281.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NUVOCO.NS's P/E ratio is 26.95. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NUVOCO.NS's ROE of +0.04%. Regarding short-term risk, ACL.BO is more volatile compared to NUVOCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NUVOCO.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NUVOCO.BO has a market cap of 103.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NUVOCO.BO trades at ₹290.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NUVOCO.BO's P/E ratio is 26.93. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NUVOCO.BO's ROE of +0.04%. Regarding short-term risk, ACL.BO is more volatile compared to NUVOCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NUVOCO.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, STARCEMENT.NS has a market cap of 83.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while STARCEMENT.NS trades at ₹201.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas STARCEMENT.NS's P/E ratio is 22.54. In terms of profitability, ACL.BO's ROE is -1.06%, compared to STARCEMENT.NS's ROE of +0.13%. Regarding short-term risk, ACL.BO is more volatile compared to STARCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check STARCEMENT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, STARCEMENT.BO has a market cap of 83.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while STARCEMENT.BO trades at ₹205.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas STARCEMENT.BO's P/E ratio is 22.55. In terms of profitability, ACL.BO's ROE is -1.06%, compared to STARCEMENT.BO's ROE of +0.13%. Regarding short-term risk, ACL.BO is less volatile compared to STARCEMENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check STARCEMENT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JKLAKSHMI.NS has a market cap of 73.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JKLAKSHMI.NS trades at ₹568.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JKLAKSHMI.NS's P/E ratio is 15.76. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JKLAKSHMI.NS's ROE of +0.13%. Regarding short-term risk, ACL.BO is more volatile compared to JKLAKSHMI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check JKLAKSHMI.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, JKLAKSHMI.BO has a market cap of 73.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while JKLAKSHMI.BO trades at ₹588.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas JKLAKSHMI.BO's P/E ratio is 15.75. In terms of profitability, ACL.BO's ROE is -1.06%, compared to JKLAKSHMI.BO's ROE of +0.13%. Regarding short-term risk, ACL.BO is less volatile compared to JKLAKSHMI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check JKLAKSHMI.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BIRLACORPN.NS has a market cap of 68.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BIRLACORPN.NS trades at ₹855.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BIRLACORPN.NS's P/E ratio is 13.23. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BIRLACORPN.NS's ROE of +0.07%. Regarding short-term risk, ACL.BO is more volatile compared to BIRLACORPN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check BIRLACORPN.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BIRLACORPN.BO has a market cap of 68.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BIRLACORPN.BO trades at ₹894.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BIRLACORPN.BO's P/E ratio is 13.13. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BIRLACORPN.BO's ROE of +0.07%. Regarding short-term risk, ACL.BO is less volatile compared to BIRLACORPN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BIRLACORPN.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, PRSMJOHNSN.BO has a market cap of 62.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while PRSMJOHNSN.BO trades at ₹124.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas PRSMJOHNSN.BO's P/E ratio is 32.11. In terms of profitability, ACL.BO's ROE is -1.06%, compared to PRSMJOHNSN.BO's ROE of +0.12%. Regarding short-term risk, ACL.BO is more volatile compared to PRSMJOHNSN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check PRSMJOHNSN.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, PRSMJOHNSN.NS has a market cap of 62.8B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while PRSMJOHNSN.NS trades at ₹123.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas PRSMJOHNSN.NS's P/E ratio is 32.05. In terms of profitability, ACL.BO's ROE is -1.06%, compared to PRSMJOHNSN.NS's ROE of +0.12%. Regarding short-term risk, ACL.BO is more volatile compared to PRSMJOHNSN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check PRSMJOHNSN.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, HEIDELBERG.NS has a market cap of 33B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while HEIDELBERG.NS trades at ₹141.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas HEIDELBERG.NS's P/E ratio is 23.69. In terms of profitability, ACL.BO's ROE is -1.06%, compared to HEIDELBERG.NS's ROE of +0.10%. Regarding short-term risk, ACL.BO is more volatile compared to HEIDELBERG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check HEIDELBERG.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, HEIDELBERG.BO has a market cap of 33B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while HEIDELBERG.BO trades at ₹145.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas HEIDELBERG.BO's P/E ratio is 25.68. In terms of profitability, ACL.BO's ROE is -1.06%, compared to HEIDELBERG.BO's ROE of +0.10%. Regarding short-term risk, ACL.BO is more volatile compared to HEIDELBERG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check HEIDELBERG.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ORIENTCEM.NS has a market cap of 27B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ORIENTCEM.NS trades at ₹126.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ORIENTCEM.NS's P/E ratio is 8.31. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ORIENTCEM.NS's ROE of +0.17%. Regarding short-term risk, ACL.BO is more volatile compared to ORIENTCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ORIENTCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ORIENTCEM.BO has a market cap of 26.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ORIENTCEM.BO trades at ₹131.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ORIENTCEM.BO's P/E ratio is 8.30. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ORIENTCEM.BO's ROE of +0.17%. Regarding short-term risk, ACL.BO is more volatile compared to ORIENTCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ORIENTCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, MANGLMCEM.NS has a market cap of 21.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while MANGLMCEM.NS trades at ₹781.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas MANGLMCEM.NS's P/E ratio is 27.25. In terms of profitability, ACL.BO's ROE is -1.06%, compared to MANGLMCEM.NS's ROE of +0.09%. Regarding short-term risk, ACL.BO is more volatile compared to MANGLMCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check MANGLMCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, MANGLMCEM.BO has a market cap of 21.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while MANGLMCEM.BO trades at ₹794.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas MANGLMCEM.BO's P/E ratio is 28.34. In terms of profitability, ACL.BO's ROE is -1.06%, compared to MANGLMCEM.BO's ROE of +0.09%. Regarding short-term risk, ACL.BO is more volatile compared to MANGLMCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check MANGLMCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SAGCEM.NS has a market cap of 21.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SAGCEM.NS trades at ₹159.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SAGCEM.NS's P/E ratio is -12.89. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SAGCEM.NS's ROE of -0.10%. Regarding short-term risk, ACL.BO is more volatile compared to SAGCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SAGCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SAGCEM.BO has a market cap of 21.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SAGCEM.BO trades at ₹164.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SAGCEM.BO's P/E ratio is -12.87. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SAGCEM.BO's ROE of -0.10%. Regarding short-term risk, ACL.BO is less volatile compared to SAGCEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check SAGCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, EPACK.NS has a market cap of 20.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while EPACK.NS trades at ₹208.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas EPACK.NS's P/E ratio is 50.94. In terms of profitability, ACL.BO's ROE is -1.06%, compared to EPACK.NS's ROE of +0.04%. Regarding short-term risk, ACL.BO is more volatile compared to EPACK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check EPACK.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, UDAICEMENT.NS has a market cap of 20.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while UDAICEMENT.NS trades at ₹36.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas UDAICEMENT.NS's P/E ratio is 201.28. In terms of profitability, ACL.BO's ROE is -1.06%, compared to UDAICEMENT.NS's ROE of +0.03%. Regarding short-term risk, ACL.BO is more volatile compared to UDAICEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check UDAICEMENT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, UDAICEMENT.BO has a market cap of 20.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while UDAICEMENT.BO trades at ₹36.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas UDAICEMENT.BO's P/E ratio is 201.06. In terms of profitability, ACL.BO's ROE is -1.06%, compared to UDAICEMENT.BO's ROE of +0.03%. Regarding short-term risk, ACL.BO is more volatile compared to UDAICEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check UDAICEMENT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KCP.BO has a market cap of 17.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KCP.BO trades at ₹134.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KCP.BO's P/E ratio is 11.56. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KCP.BO's ROE of +0.09%. Regarding short-term risk, ACL.BO is less volatile compared to KCP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check KCP.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KCP.NS has a market cap of 17.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KCP.NS trades at ₹129.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KCP.NS's P/E ratio is 11.50. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KCP.NS's ROE of +0.09%. Regarding short-term risk, ACL.BO is more volatile compared to KCP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check KCP.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SANGHIIND.BO has a market cap of 12.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SANGHIIND.BO trades at ₹50.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SANGHIIND.BO's P/E ratio is -3.05. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SANGHIIND.BO's ROE of -0.69%. Regarding short-term risk, ACL.BO is more volatile compared to SANGHIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SANGHIIND.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SANGHIIND.NS has a market cap of 12.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SANGHIIND.NS trades at ₹49.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SANGHIIND.NS's P/E ratio is -3.01. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SANGHIIND.NS's ROE of -0.69%. Regarding short-term risk, ACL.BO is more volatile compared to SANGHIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SANGHIIND.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SHREDIGCEM.BO has a market cap of 9.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SHREDIGCEM.BO trades at ₹63.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SHREDIGCEM.BO's P/E ratio is 26.86. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SHREDIGCEM.BO's ROE of +0.10%. Regarding short-term risk, ACL.BO is less volatile compared to SHREDIGCEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check SHREDIGCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, IFGLEXPOR.BO has a market cap of 9.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while IFGLEXPOR.BO trades at ₹131.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas IFGLEXPOR.BO's P/E ratio is 32.91. In terms of profitability, ACL.BO's ROE is -1.06%, compared to IFGLEXPOR.BO's ROE of +0.03%. Regarding short-term risk, ACL.BO is less volatile compared to IFGLEXPOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check IFGLEXPOR.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, IFGLEXPOR.NS has a market cap of 9.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while IFGLEXPOR.NS trades at ₹127.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas IFGLEXPOR.NS's P/E ratio is 32.89. In terms of profitability, ACL.BO's ROE is -1.06%, compared to IFGLEXPOR.NS's ROE of +0.03%. Regarding short-term risk, ACL.BO is more volatile compared to IFGLEXPOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check IFGLEXPOR.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SHREDIGCEM.NS has a market cap of 9.5B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SHREDIGCEM.NS trades at ₹62.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SHREDIGCEM.NS's P/E ratio is 26.66. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SHREDIGCEM.NS's ROE of +0.10%. Regarding short-term risk, ACL.BO is more volatile compared to SHREDIGCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SHREDIGCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, APOLLOPIPES.BO has a market cap of 9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while APOLLOPIPES.BO trades at ₹686.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas APOLLOPIPES.BO's P/E ratio is 46.89. In terms of profitability, ACL.BO's ROE is -1.06%, compared to APOLLOPIPES.BO's ROE of +0.02%. Regarding short-term risk, ACL.BO is more volatile compared to APOLLOPIPES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check APOLLOPIPES.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, DECCANCE.NS has a market cap of 8.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while DECCANCE.NS trades at ₹578.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas DECCANCE.NS's P/E ratio is 25.91. In terms of profitability, ACL.BO's ROE is -1.06%, compared to DECCANCE.NS's ROE of +0.04%. Regarding short-term risk, ACL.BO is less volatile compared to DECCANCE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check DECCANCE.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, DECCANCE.BO has a market cap of 8.2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while DECCANCE.BO trades at ₹586.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas DECCANCE.BO's P/E ratio is 24.79. In terms of profitability, ACL.BO's ROE is -1.06%, compared to DECCANCE.BO's ROE of +0.04%. Regarding short-term risk, ACL.BO is less volatile compared to DECCANCE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check DECCANCE.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ORIRAIL.BO has a market cap of 7.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ORIRAIL.BO trades at ₹114.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ORIRAIL.BO's P/E ratio is 20.68. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ORIRAIL.BO's ROE of +0.10%. Regarding short-term risk, ACL.BO is less volatile compared to ORIRAIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ORIRAIL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NCLIND.BO has a market cap of 7.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NCLIND.BO trades at ₹157.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NCLIND.BO's P/E ratio is 14.37. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NCLIND.BO's ROE of +0.07%. Regarding short-term risk, ACL.BO is more volatile compared to NCLIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NCLIND.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NCLIND.NS has a market cap of 7.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NCLIND.NS trades at ₹154.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NCLIND.NS's P/E ratio is 11.78. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NCLIND.NS's ROE of +0.07%. Regarding short-term risk, ACL.BO is more volatile compared to NCLIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NCLIND.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SAURASHCEM.NS has a market cap of 6.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SAURASHCEM.NS trades at ₹53.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SAURASHCEM.NS's P/E ratio is 21.39. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SAURASHCEM.NS's ROE of +0.03%. Regarding short-term risk, ACL.BO is more volatile compared to SAURASHCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SAURASHCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SAURASHCEM.BO has a market cap of 6.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SAURASHCEM.BO trades at ₹54.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SAURASHCEM.BO's P/E ratio is 21.35. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SAURASHCEM.BO's ROE of +0.03%. Regarding short-term risk, ACL.BO is less volatile compared to SAURASHCEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check SAURASHCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SHIVACEM.BO has a market cap of 4.4B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SHIVACEM.BO trades at ₹15.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SHIVACEM.BO's P/E ratio is -3.02. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SHIVACEM.BO's ROE of -1.37%. Regarding short-term risk, ACL.BO is less volatile compared to SHIVACEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check SHIVACEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ACL.NS has a market cap of 3.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ACL.NS trades at ₹42.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ACL.NS's P/E ratio is -2.38. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ACL.NS's ROE of -1.06%. Regarding short-term risk, ACL.BO is more volatile compared to ACL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ACL.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ZODIAC.NS has a market cap of 3.7B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ZODIAC.NS trades at ₹234.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ZODIAC.NS's P/E ratio is 64.73. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ZODIAC.NS's ROE of +0.21%. Regarding short-term risk, ACL.BO is more volatile compared to ZODIAC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check ZODIAC.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ZODIAC.BO has a market cap of 3.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ZODIAC.BO trades at ₹241.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ZODIAC.BO's P/E ratio is -57.27. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ZODIAC.BO's ROE of +0.21%. Regarding short-term risk, ACL.BO is less volatile compared to ZODIAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ZODIAC.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NAVKAR.BO has a market cap of 3.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NAVKAR.BO trades at ₹14.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NAVKAR.BO's P/E ratio is 145.10. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NAVKAR.BO's ROE of -0.01%. Regarding short-term risk, ACL.BO is less volatile compared to NAVKAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check NAVKAR.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, APCL.NS has a market cap of 3.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while APCL.NS trades at ₹108.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas APCL.NS's P/E ratio is -7.53. In terms of profitability, ACL.BO's ROE is -1.06%, compared to APCL.NS's ROE of -0.18%. Regarding short-term risk, ACL.BO is more volatile compared to APCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check APCL.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, APCL.BO has a market cap of 3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while APCL.BO trades at ₹103.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas APCL.BO's P/E ratio is -7.42. In terms of profitability, ACL.BO's ROE is -1.06%, compared to APCL.BO's ROE of -0.18%. Regarding short-term risk, ACL.BO is less volatile compared to APCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check APCL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GSCLCEMENT.NS has a market cap of 3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GSCLCEMENT.NS trades at ₹33.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GSCLCEMENT.NS's P/E ratio is -87.37. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GSCLCEMENT.NS's ROE of +0.04%. Regarding short-term risk, ACL.BO is more volatile compared to GSCLCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check GSCLCEMENT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KESORAMIND.BO has a market cap of 2.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KESORAMIND.BO trades at ₹8.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KESORAMIND.BO's P/E ratio is -1.83. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KESORAMIND.BO's ROE of +18.55%. Regarding short-term risk, ACL.BO is less volatile compared to KESORAMIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check KESORAMIND.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KESORAMIND.NS has a market cap of 2.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KESORAMIND.NS trades at ₹8.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KESORAMIND.NS's P/E ratio is -1.82. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KESORAMIND.NS's ROE of +18.55%. Regarding short-term risk, ACL.BO is less volatile compared to KESORAMIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check KESORAMIND.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SAHYADRI.NS has a market cap of 2.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SAHYADRI.NS trades at ₹208.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SAHYADRI.NS's P/E ratio is 10.08. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SAHYADRI.NS's ROE of +0.06%. Regarding short-term risk, ACL.BO is more volatile compared to SAHYADRI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check SAHYADRI.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, SKCIL.BO has a market cap of 2.3B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while SKCIL.BO trades at ₹130.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas SKCIL.BO's P/E ratio is -198.11. In terms of profitability, ACL.BO's ROE is -1.06%, compared to SKCIL.BO's ROE of -0.01%. Regarding short-term risk, ACL.BO is less volatile compared to SKCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check SKCIL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GSLSU.NS has a market cap of 2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GSLSU.NS trades at ₹46.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GSLSU.NS's P/E ratio is -10.63. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GSLSU.NS's ROE of -0.06%. Regarding short-term risk, ACL.BO is more volatile compared to GSLSU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check GSLSU.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GSLSU.BO has a market cap of 2B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GSLSU.BO trades at ₹46.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GSLSU.BO's P/E ratio is -10.59. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GSLSU.BO's ROE of -0.06%. Regarding short-term risk, ACL.BO is less volatile compared to GSLSU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check GSLSU.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ASIIL.BO has a market cap of 1.9B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ASIIL.BO trades at ₹21.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ASIIL.BO's P/E ratio is 7.31. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ASIIL.BO's ROE of +0.08%. Regarding short-term risk, ACL.BO is less volatile compared to ASIIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ASIIL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BRPL.BO has a market cap of 1.6B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BRPL.BO trades at ₹122.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BRPL.BO's P/E ratio is 18.14. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BRPL.BO's ROE of +0.27%. Regarding short-term risk, ACL.BO is less volatile compared to BRPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BRPL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ALUWIND.NS has a market cap of 1.4B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ALUWIND.NS trades at ₹55.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ALUWIND.NS's P/E ratio is 12.56. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ALUWIND.NS's ROE of N/A. Regarding short-term risk, ACL.BO is less volatile compared to ALUWIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ALUWIND.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, TRL.BO has a market cap of 1.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while TRL.BO trades at ₹92.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas TRL.BO's P/E ratio is 27.52. In terms of profitability, ACL.BO's ROE is -1.06%, compared to TRL.BO's ROE of +0.06%. Regarding short-term risk, ACL.BO is more volatile compared to TRL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check TRL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KEIL.BO has a market cap of 1.1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KEIL.BO trades at ₹13.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KEIL.BO's P/E ratio is -1317.00. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KEIL.BO's ROE of -0.00%. Regarding short-term risk, ACL.BO is less volatile compared to KEIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check KEIL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, GLITTEKG.BO has a market cap of 1B. Regarding current trading prices, ACL.BO is priced at ₹42.63, while GLITTEKG.BO trades at ₹39.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas GLITTEKG.BO's P/E ratio is 4.00. In terms of profitability, ACL.BO's ROE is -1.06%, compared to GLITTEKG.BO's ROE of +4.29%. Regarding short-term risk, ACL.BO is more volatile compared to GLITTEKG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check GLITTEKG.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, RISHILASE.BO has a market cap of 984.3M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while RISHILASE.BO trades at ₹107.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas RISHILASE.BO's P/E ratio is 12.42. In terms of profitability, ACL.BO's ROE is -1.06%, compared to RISHILASE.BO's ROE of +0.10%. Regarding short-term risk, ACL.BO is less volatile compared to RISHILASE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check RISHILASE.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NILACHAL.BO has a market cap of 946.6M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NILACHAL.BO trades at ₹46.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NILACHAL.BO's P/E ratio is -3.89. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NILACHAL.BO's ROE of +1.06%. Regarding short-term risk, ACL.BO is more volatile compared to NILACHAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NILACHAL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, PANCM.BO has a market cap of 874.3M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while PANCM.BO trades at ₹109.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas PANCM.BO's P/E ratio is -0.98. In terms of profitability, ACL.BO's ROE is -1.06%, compared to PANCM.BO's ROE of +0.39%. Regarding short-term risk, ACL.BO is more volatile compared to PANCM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check PANCM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, PACIFICI.BO has a market cap of 871.2M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while PACIFICI.BO trades at ₹126.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas PACIFICI.BO's P/E ratio is 22.14. In terms of profitability, ACL.BO's ROE is -1.06%, compared to PACIFICI.BO's ROE of +0.01%. Regarding short-term risk, ACL.BO is less volatile compared to PACIFICI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check PACIFICI.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NAVKARURB.BO has a market cap of 841.6M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NAVKARURB.BO trades at ₹0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NAVKARURB.BO's P/E ratio is -10.71. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NAVKARURB.BO's ROE of +0.00%. Regarding short-term risk, ACL.BO is less volatile compared to NAVKARURB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check NAVKARURB.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, NAVKARURB.NS has a market cap of 830.3M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while NAVKARURB.NS trades at ₹0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas NAVKARURB.NS's P/E ratio is -10.57. In terms of profitability, ACL.BO's ROE is -1.06%, compared to NAVKARURB.NS's ROE of +0.00%. Regarding short-term risk, ACL.BO is more volatile compared to NAVKARURB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check NAVKARURB.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BVCL.NS has a market cap of 808.2M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BVCL.NS trades at ₹35.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BVCL.NS's P/E ratio is 3647.00. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BVCL.NS's ROE of +0.00%. Regarding short-term risk, ACL.BO is less volatile compared to BVCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BVCL.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BVCL.BO has a market cap of 805.1M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BVCL.BO trades at ₹36.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BVCL.BO's P/E ratio is 3633.00. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BVCL.BO's ROE of +0.00%. Regarding short-term risk, ACL.BO is less volatile compared to BVCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BVCL.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KAKATCEM.BO has a market cap of 723.7M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KAKATCEM.BO trades at ₹93.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KAKATCEM.BO's P/E ratio is -2.66. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KAKATCEM.BO's ROE of -0.13%. Regarding short-term risk, ACL.BO is less volatile compared to KAKATCEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check KAKATCEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, KAKATCEM.NS has a market cap of 719.9M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while KAKATCEM.NS trades at ₹90.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas KAKATCEM.NS's P/E ratio is -2.62. In terms of profitability, ACL.BO's ROE is -1.06%, compared to KAKATCEM.NS's ROE of -0.13%. Regarding short-term risk, ACL.BO is more volatile compared to KAKATCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check KAKATCEM.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, REFRACTORY.NS has a market cap of 655.1M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while REFRACTORY.NS trades at ₹30.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas REFRACTORY.NS's P/E ratio is 10.81. In terms of profitability, ACL.BO's ROE is -1.06%, compared to REFRACTORY.NS's ROE of N/A. Regarding short-term risk, ACL.BO is more volatile compared to REFRACTORY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check REFRACTORY.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, CEETAIN.BO has a market cap of 611.9M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while CEETAIN.BO trades at ₹42.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas CEETAIN.BO's P/E ratio is 168.76. In terms of profitability, ACL.BO's ROE is -1.06%, compared to CEETAIN.BO's ROE of +0.01%. Regarding short-term risk, ACL.BO is more volatile compared to CEETAIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check CEETAIN.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, RESTILE.BO has a market cap of 609.3M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while RESTILE.BO trades at ₹6.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas RESTILE.BO's P/E ratio is -88.57. In terms of profitability, ACL.BO's ROE is -1.06%, compared to RESTILE.BO's ROE of +0.00%. Regarding short-term risk, ACL.BO is less volatile compared to RESTILE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check RESTILE.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BURNPUR.NS has a market cap of 568.4M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BURNPUR.NS trades at ₹33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BURNPUR.NS's P/E ratio is -0.21. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BURNPUR.NS's ROE of +0.10%. Regarding short-term risk, ACL.BO is less volatile compared to BURNPUR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BURNPUR.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ELEMARB.BO has a market cap of 565.3M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ELEMARB.BO trades at ₹154.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ELEMARB.BO's P/E ratio is 12.85. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ELEMARB.BO's ROE of +0.02%. Regarding short-term risk, ACL.BO is less volatile compared to ELEMARB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ELEMARB.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, AHMDSTE.BO has a market cap of 532M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while AHMDSTE.BO trades at ₹130.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas AHMDSTE.BO's P/E ratio is 10.83. In terms of profitability, ACL.BO's ROE is -1.06%, compared to AHMDSTE.BO's ROE of +0.22%. Regarding short-term risk, ACL.BO is less volatile compared to AHMDSTE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check AHMDSTE.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, BHEEMACEM.BO has a market cap of 526.7M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while BHEEMACEM.BO trades at ₹16.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas BHEEMACEM.BO's P/E ratio is -1.56. In terms of profitability, ACL.BO's ROE is -1.06%, compared to BHEEMACEM.BO's ROE of -5.24%. Regarding short-term risk, ACL.BO is less volatile compared to BHEEMACEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check BHEEMACEM.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, DIVSHKT.BO has a market cap of 491.4M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while DIVSHKT.BO trades at ₹47.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas DIVSHKT.BO's P/E ratio is 33.94. In terms of profitability, ACL.BO's ROE is -1.06%, compared to DIVSHKT.BO's ROE of +0.01%. Regarding short-term risk, ACL.BO is less volatile compared to DIVSHKT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check DIVSHKT.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, EFORCE.NS has a market cap of 457.5M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while EFORCE.NS trades at ₹19.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas EFORCE.NS's P/E ratio is 35.55. In terms of profitability, ACL.BO's ROE is -1.06%, compared to EFORCE.NS's ROE of N/A. Regarding short-term risk, ACL.BO is more volatile compared to EFORCE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ACL.BO.Check EFORCE.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ANDHRACEMT.NS has a market cap of 456.2M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ANDHRACEMT.NS trades at ₹4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ANDHRACEMT.NS's P/E ratio is -0.03. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ANDHRACEMT.NS's ROE of -0.20%. Regarding short-term risk, ACL.BO is less volatile compared to ANDHRACEMT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ANDHRACEMT.NS's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, ZWELCAST.BO has a market cap of 451.8M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while ZWELCAST.BO trades at ₹707.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas ZWELCAST.BO's P/E ratio is -0.07. In terms of profitability, ACL.BO's ROE is -1.06%, compared to ZWELCAST.BO's ROE of -0.17%. Regarding short-term risk, ACL.BO is less volatile compared to ZWELCAST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check ZWELCAST.BO's competition here

ACL.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACL.BO stands at 3.9B. In comparison, MAYUKH.BO has a market cap of 432M. Regarding current trading prices, ACL.BO is priced at ₹42.63, while MAYUKH.BO trades at ₹2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACL.BO currently has a P/E ratio of -2.37, whereas MAYUKH.BO's P/E ratio is 56.25. In terms of profitability, ACL.BO's ROE is -1.06%, compared to MAYUKH.BO's ROE of +0.09%. Regarding short-term risk, ACL.BO is less volatile compared to MAYUKH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ACL.BO.Check MAYUKH.BO's competition here